Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Luma Group Successfully Closes LumaBio Fund I at $410 Million

Summary by PR Newswire
/PRNewswire/ -- Luma Group ("the Firm"), a New York-based investment firm focused on life sciences, today announced the successful final close of LumaBio I LP...

2 Articles

PR NewswirePR Newswire
Center

Luma Group Successfully Closes LumaBio Fund I at $410 Million

/PRNewswire/ -- Luma Group ("the Firm"), a New York-based investment firm focused on life sciences, today announced the successful final close of LumaBio I LP...

·Chicago, United States
Read Full Article
altassets.netaltassets.net

Luma closes $410m debut life-sciences fund after scoring $1.55bn first exit

New York investment firm Luma Group has closed its debut life-sciences venture fund on $410m, in the wake of securing its first portfolio-company exit through Eli Lilly’s acquisition of Vaccine Company.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

PR Newswire broke the news in Chicago, United States on Wednesday, September 9, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Eli Lilly icon

Eli Lilly

New York City icon

New York City

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal